Quantitative real time-PCR and western blot analysis were performed to detect microRNAs and Forkhead box Q1 protein expression, respectively. The breast CSCs were characterized by aldehyde dehydrogenase 1 activity and flow cytometric analysis of CD49f high/CD133high fraction.
[Pharmaceutical Research]